Inhibrx Biosciences - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Representative image: Oracle (NYSE: ORCL) stock jumps 13% on record cloud earnings and multicloud momentum

Oracle (NYSE: ORCL) rallies 10% after earnings as $553bn RPO signals AI infrastructure dominance

Agentic AI arms race: Zendesk and Forethought challenge Salesforce Agentforce and ServiceNow Moveworks

Representative image of a cloud data center environment illustrating enterprise legacy system migration to Microsoft Azure, reflecting Kyndryl’s Cloud Uplift expansion in Canada to modernize mission-critical workloads while keeping data within national datacentre regions.

The quiet legacy cloud migration battle is heating up and Kyndryl just made a strategic move in Canada

Representative image of liquid-cooled AI server hardware inside a hyperscale data center, illustrating the type of direct-to-chip cooling infrastructure being developed through the Flex and Broadcom collaboration to support next-generation AI XPUs and high-density artificial intelligence workloads.

AI chips are overheating. Can Flex and Broadcom fix the cooling crisis?

Read More

5 minute read

Pharma Industry News

Inhibrx Biosciences’ Ozekibart sets new benchmark in rare bone cancer treatment and advances toward 2026 BLA filing

Find out how Inhibrx Biosciences’ Ozekibart delivered breakthrough results in chondrosarcoma and is advancing toward a 2026 BLA filing—read more now!

bySoujanya Ravi

October 24, 2025

web analytics